• Dr.P.KISHORE
• K.Supraja
• D.Sudheer Kumar

Rheumatoid Arthritis is an autoimmune mediated condition which affects the joints but with critical extra articular manifestations, including a significantly increased cardiovascular risk. Patients suffering from rheumatoid arthritis can develop deforming and disabling alterations of the affected joints. In majority of patients with established rheumatoid arthritis anticitrullinated protein antibodies can be found. Antibody therapies inhibiting Tumour necrosis factor-alpha patients with active rheumatoid arthritis have set a new standard in terms of rapid and sustained improvements in symptoms and signs of disease, improvements in ‘quality of life’ and protection of joints from structural damage.

Rheumatoid Arthritis, Anticitrullinated antibodies, Tumour necrosis factor-alpha

"ROLE OF MONOCLONAL ANTIBODIES IN RHEUMATOID ARTHRITIS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 3, page no.595-601, March-2020, Available :http://www.jetir.org/papers/JETIR2003093.pdf

"ROLE OF MONOCLONAL ANTIBODIES IN RHEUMATOID ARTHRITIS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 3, page no. pp595-601, March-2020, Available at : http://www.jetir.org/papers/JETIR2003093.pdf